Intensive blood pressure treatment targeting systolic blood pressure <120 mm Hg results in lower rates of major adverse cardiovascular events and lower all-cause mortality than a standard treatment target among patients at increased cardiovascular risk, according to a study published in the May 20 issue of the New England Journal of Medicine. Cora E. Lewis, M.D., M.S.P.H., from...
